| 0 | ℹ |
CRISPR-Cas3-based editing for targeted deletions in a mouse model of transthyretin amyloidosis.
(nature.com)
|
Nature Biotechnology 2026-01-05 | #crispr #gene therapy #genome editing #amyloid |